Home › Funds › 12 West Capital Management LP › RGEN

12 West Capital Management LP position in RGEN

REPLIGEN CORP · Health Care

12 West Capital Management LP reported holding 262,712 shares of RGEN (REPLIGEN CORP) in its Q3 2026 13F filing — a position valued at US$50.5M, representing 9.60% of its reported portfolio and ranking #3 among its reported holdings. 12 West Capital Management LP has disclosed RGEN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)262.71K sh
Reported value held$50.50M
Portfolio Weight9.60%
First reportedQ3 2023
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How 12 West Capital Management LP's RGEN position evolved

12 West Capital Management LP first disclosed a stake in RGEN in Q3 2023 at 414,217 shares (US$65.9M). The position peaked in Q4 2023 at 368,245 shares, worth US$66.2M. Across 13 filings, 12 West Capital Management LP increased the stake 1 time(s), trimmed it 6 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 262,712 shares valued at US$50.5M — a reduction of -17,453 shares quarter over quarter.. Notable position changes include a 31% trim in Q1 2024 (shares fell 31% over the following quarter), a 47% increase in Q2 2026 (shares rose 41% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 414.22K $65.86M New
Q4 2023 368.25K $66.21M Reduce
Q1 2024 252.85K $46.50M Reduce
Q2 2024 252.85K $31.87M Hold
Q3 2024 252.85K $37.63M Hold
Q4 2024 246.88K $35.54M Reduce
Q1 2025 241.23K $30.69M Reduce
Q2 2025 241.23K $30.00M Hold
Q3 2025 241.23K $32.25M Hold
Q4 2025 241.23K $39.53M Hold
Q1 2026 191.23K $22.53M Reduce
Q2 2026 280.17K $38.23M Add
Q3 2026 262.71K $50.50M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RGEN and 13F data

RGEN (REPLIGEN CORP) is a Health Care company. 35 other funds we track also report a position in RGEN — the largest reported positions include UNITED CAPITAL FINANCIAL ADVISORS, LLC (US$536.3M), Maverick Capital (US$270.8M), MAVERICK CAPITAL LTD (US$270.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RGEN

All RGEN fund holders →

FAQ

How long has 12 West Capital Management LP held RGEN?

12 West Capital Management LP has disclosed RGEN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is 12 West Capital Management LP's current position in RGEN?

As of Q3 2026, 12 West Capital Management LP holds 262.71K shares of RGEN (REPLIGEN CORP), valued at $50.50M, representing 9.60% of its reported portfolio and ranking #3.

Has 12 West Capital Management LP been buying or selling RGEN?

In the latest 13F filing (Q3 2026), 12 West Capital Management LP reduced its position in RGEN. The position peaked in Q4 2023 at 368.25K shares.

Which other funds hold RGEN?

Other major institutional holders of RGEN include UNITED CAPITAL FINANCIAL ADVISORS, LLC, Maverick Capital, MAVERICK CAPITAL LTD, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.